Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 30 entries
View as:

SUNOSI® (Solriamfetol) Pregnancy Registry

Phase: N/A Priority: Normal
NCT ID: NCT06413420 Org: User:
Start: 07/31/19 End: 09/30/29 Due: 09/30/30

Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-controlled Study

Phase: N/A Priority: Normal
NCT ID: NCT04789174 Org: User:
Start: 05/17/21 End: 09/19/22 Due: 09/19/23

A Study to Assess the Efficacy and Safety of Solriamfetol in Subjects With ADHD (FOCUS)

Phase: N/A Priority: Normal
NCT ID: NCT05972044 Org: User:
Start: 07/06/23 End: 03/14/25 Due: 03/14/26

Assessing Symptomatic Clinical Episodes in Depression

Phase: N/A Priority: Normal
NCT ID: NCT03595579 Org: User:
Start: 05/30/18 End: 01/07/19 Due: 01/07/20

Maximizing Outcomes in Treating Acute Migraine

Phase: N/A Priority: Normal
NCT ID: NCT03896009 Org: User:
Start: 03/04/19 End: 12/10/19 Due: 12/10/20

Multimechanistic Treatment Over Time of Migraine Symptoms (MOVEMENT)

Phase: N/A Priority: Normal
NCT ID: NCT04068051 Org: User:
Start: 07/06/19 End: 09/22/20 Due: 09/22/21

CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1

Phase: N/A Priority: Normal
NCT ID: NCT02504008 Org: User:
Start: 07/31/15 End: 01/31/19 Due: 01/31/20

Initiating Early Control of Migraine Pain and Associated Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT04163185 Org: User:
Start: 10/08/19 End: 03/23/20 Due: 03/23/21

Open-Label Safety Study of AXS-05 in Subjects With TRD (EVOLVE)

Phase: N/A Priority: Normal
NCT ID: NCT04634669 Org: User:
Start: 09/23/20 End: 03/04/22 Due: 03/04/23

A Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease Agitation

Phase: N/A Priority: Normal
NCT ID: NCT04947553 Org: User:
Start: 06/17/21 End: 12/21/24 Due: 12/21/25

Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using Solriamfetol

Phase: N/A Priority: Normal
NCT ID: NCT06360419 Org: User:
Start: 03/18/24 End: 03/26/25 Due: 03/26/26

Clinical Outcomes in Narcolepsy and Cataplexy: An Evaluation of Reboxetine Treatment (CONCERT)

Phase: N/A Priority: Normal
NCT ID: NCT03881852 Org: User:
Start: 01/30/19 End: 11/27/19 Due: 11/27/20

Evaluate Sunosi® PK in Breast Milk and Plasma of Healthy Postpartum Women Following Single Dose Oral Administration

Phase: N/A Priority: Normal
NCT ID: NCT05008341 Org: User:
Start: 08/27/21 End: 04/15/22 Due: 04/15/23

A Study to Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects with Narcolepsy (ENCORE)

Phase: N/A Priority: Normal
NCT ID: NCT05113745 Org: User:
Start: 10/20/21 End: 11/15/24 Due: 11/15/25

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT06223880 Org: User:
Start: 12/27/23 End: 03/31/26 Due: 03/31/27

Addressing Dementia Via Agitation-Centered Evaluation

Phase: N/A Priority: Normal
NCT ID: NCT03226522 Org: User:
Start: 07/13/17 End: 04/17/20 Due: 04/17/21

A Trial of AXS-05 in Patients With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT04019704 Org: User:
Start: 06/20/19 End: 12/05/19 Due: 12/05/20

A Study to Assess the Efficacy and Safety of AXS-05 in Subjects with Alzheimer's Disease Agitation

Phase: N/A Priority: Normal
NCT ID: NCT05557409 Org: User:
Start: 09/06/22 End: 12/21/24 Due: 12/21/25

An Evaluation of AXS-05 for the Treatment of TRD in Treatment-Adherent Patients

Phase: N/A Priority: Normal
NCT ID: NCT04971291 Org: User:
Start: 04/14/21 End: 07/31/21 Due: 07/31/22

Open-Label Study of AXS-07 for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor (EMERGE)

Phase: N/A Priority: Normal
NCT ID: NCT05550207 Org: User:
Start: 08/31/22 End: 11/27/24 Due: 11/27/25

Open-Label Safety Study of AXS-05 in Subjects With Depression

Phase: N/A Priority: Normal
NCT ID: NCT04039022 Org: User:
Start: 07/08/19 End: 10/23/20 Due: 10/23/21

A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy

Phase: N/A Priority: Normal
NCT ID: NCT05059223 Org: User:
Start: 09/15/21 End: 03/15/24 Due: 03/15/25

Open-Label Safety Study of Solriamfetol in Subjects with Binge Eating Disorder

Phase: N/A Priority: Normal
NCT ID: NCT06878976 Org: User:
Start: 02/20/25 End: 12/31/26 Due: 12/31/27

An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension Study

Phase: N/A Priority: Normal
NCT ID: NCT06736509 Org: User:
Start: 11/21/24 End: 04/25/25 Due: 04/25/26

Assessing Clinical Outcomes in Alzheimer's Disease Agitation

Phase: N/A Priority: Normal
NCT ID: NCT04797715 Org: User:
Start: 12/31/20 End: 11/21/22 Due: 11/21/23